Polymer Factory Sweden AB receives order of approx. SEK 300,000 from a global biotech company

Polymer Factory today announces an order of significant size, as a global biotech company has placed an order amounting to approximately SEK 300,000. The order is placed as a next phase of evaluations, following an order that was delivered in Q4 2021. 

Purchasing products from Polymer Factory’s portfolio of dendritic materials, a global biotech company has placed an order of EUR 28,500, amounting to approximately SEK 300,000. The products purchased are customized and will be used by the customer for product development purposes. The order is a result of successful evaluation of previously delivered products.

Products are expected to be delivered to the customer during Q3 2022 and may lead to continued business opportunities upon successful product development.

About Polymer Factory

Polymer Factory was founded in 2006 at KTH Royal Institute of Technology and its Board of Directors have been essential in driving dendritic nanotechnology research to commercialization for almost 15 years – expertise that has been transferred to the Company’s products. Emerging from many years of cutting-edge research within the field, Polymer Factory today has, in the Company’s assessment, the world’s largest product portfolio of dendritic materials with customers ranging from Big Pharma, MedTech and BioTech companies, to research-intensive institutes and academic research groups. Polymer Factory has also used the Company’s vast knowledge and expertise to develop a patented calibration technology, named SpheriCal®, designed for Mass Spectrometry instruments.

This disclosure contains information that Polymer Factory is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 23-08-2022 14:47 CET.